Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-029802
Filing Date
2026-05-04
Accepted
2026-05-04 16:10:32
Documents
93
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 1Q26 FORM 10-Q mrk-20260331.htm   iXBRL 10-Q 2074889
2 EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO exhibit311-rule13ax14a15dx.htm EX-31.1 8388
3 EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO exhibit312-rule13ax14a15dx.htm EX-31.2 8234
4 EX-32.1 SECTION 1350 CERTIFICATION OF CEO exhibit321-section1350cert.htm EX-32.1 3867
5 EX-32.2 SECTION 1350 CERTIFICATION OF CFO exhibit322-section1350cert.htm EX-32.2 3715
  Complete submission text file 0001628280-26-029802.txt   12552690

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20260331.xsd EX-101.SCH 68753
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrk-20260331_cal.xml EX-101.CAL 83611
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20260331_def.xml EX-101.DEF 466278
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20260331_lab.xml EX-101.LAB 786638
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20260331_pre.xml EX-101.PRE 661160
97 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20260331_htm.xml XML 2655212
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 26937670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)